跳至主要内容
临床试验/JPRN-UMIN000053980
JPRN-UMIN000053980已完成4 期

Bone Morphogenetic Protein-2 Levels in Gingival Crevicular Fluid Following Hydroxyapatite Tricalcium Phosphat Bone Graft in Vertical Defect, A Randomized Controlled Trial - Bone Morphogenetic Protein-2 Levels in Gingival Crevicular Fluid Following Hydroxyapatite Tricalcium Phosphat Bone Graft in Vertical Defect, A Randomized Controlled Trial:Bone Morphogenetic Protein-2 Levels in Gingival Crevicular Fluid Following Hydroxyapatite Tricalcium Phosphat Bone Graft in Vertical Defect, A Randomized Controlled Trial

Indonesian Agency for the Assessment and Application of Technology and Dental Faculty Universitas Padjadjaran, Indonesia0 个研究点目标入组 32 人开始时间: 2024年3月31日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
32

研究概览

简要总结

There was an increase in BMP-2 levels in the treatment group.

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion patients included patients diagnosed with aggressive periodontitis, pregnant and lactating women, wearing orthodontic appliances, taking antibiotics, anti-inflammatory and immunosuppressants for the last three months, and having a history of uncontrolled systemic disease

研究者

发起方
Indonesian Agency for the Assessment and Application of Technology and Dental Faculty Universitas Padjadjaran, Indonesia

相似试验